Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage

NCT01298830 is registered in ClinicalTrials.gov with CellMed AG, a subsidiary of BTG plc. as lead sponsor.

NCT NCT01298830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01298830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage
Lead sponsor
CellMed AG, a subsidiary of BTG plc.
Phase
Phase 1/2
Overall status
Terminated
Start date
October 31, 2008
Completion date
June 30, 2011
Enrollment
11 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage (ich)